NCT04513678View on ClinicalTrials.gov

Development of ImmunOncoTool

NACompletedINTERVENTIONAL

Enrollment

64

Participants

Timeline

Start Date

December 18, 2019

Primary Completion Date

December 17, 2021

Study Completion Date

December 17, 2021

Conditions

CancerCancer, Treatment-Related

Interventions

BEHAVIORAL

ImmunOncoTool Condition

Immunotherapy education + irAE monitoring + Facilitation of patient-provider communication

Trial Locations (1)

60611

Northwestern University, Chicago

Sponsors

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

American Cancer Society, Inc.

OTHER

collaborator

Bristol-Myers Squibb

INDUSTRY

collaborator

Melanoma Research Foundation Breakthrough Consortium

OTHER

lead

Northwestern University

OTHER